ABVC (ABVC BioPharma) Change In Inventory: $0.00 Mil (TTM As of Mar. 2026)

What is ABVC BioPharma Change In Inventory?

ABVC BioPharma ABVC -1.13% 17 Change In Inventory is $0.00 Mil as of Mar. 2026. GuruFocus rates ABVC with a GF Score™ of 17/100 and a GF Value™ of $0.87 (Significantly Overvalued). The stock has 1 warning sign investors should review.

ABVC BioPharma's change in inventory for the quarter that ended in Mar. 2026 was $0.00 Mil. It means ABVC BioPharma's inventory stayed the same from Dec. 2025 to Mar. 2026 .

ABVC BioPharma's change in inventory for the fiscal year that ended in Dec. 2025 was $-0.01 Mil. It means ABVC BioPharma's inventory increased by $0.01 Mil from Dec. 2024 to Dec. 2025 .

ABVC BioPharma's Total Inventories for the quarter that ended in Mar. 2026 was $0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

ABVC BioPharma (NAS:ABVC) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

ABVC BioPharma's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	0	*	365 / 4
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

ABVC BioPharma's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

ABVC BioPharma's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0
	=	N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ABVC BioPharma Change In Inventory Related Terms

ABVC BioPharma Change In Inventory Historical Data

* Premium members only.

The historical data trend for ABVC BioPharma's Change In Inventory can be seen below:

ABVC BioPharma Change In Inventory Chart

ABVC BioPharma Annual Data

Trend

Sep16

Sep17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Change In Inventory

Get a 7-Day Free Trial

-0.03

0.00

-0.01

ABVC BioPharma Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Change In Inventory	Get a 7-Day Free Trial															-0.01	0.00	0.00	0.00	0.00

17GF Score

ABVC BioPharma Inc ABVC

Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

ABVC BioPharma Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Frequently Asked Questions Learn more about Change In Inventory →

What does a Change In Inventory of $0.00 Mil mean?

ABVC BioPharma (ABVC) has a Change In Inventory of $0.00 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for ABVC BioPharma and its competitors.

Is ABVC BioPharma's Change In Inventory too high?

ABVC BioPharma's current Change In Inventory is $0.00 Mil. Overall, ABVC BioPharma has a GF Score™ of 17/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does ABVC BioPharma's Change In Inventory compare to GRCE and ELOX?

ABVC BioPharma's Change In Inventory of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Change In Inventory for a Biotechnology company?

A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Change In Inventory mean?

A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for ABVC BioPharma and its competitors. ABVC BioPharma's current Change In Inventory is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is ABVC BioPharma stock overvalued right now?

Based on GuruFocus' analysis, ABVC BioPharma (ABVC) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.87, compared to a current price of $1.75 — trading 101.1% above its estimated fair value. The current Change In Inventory is $0.00 Mil. ABVC BioPharma's overall GF Score™ is 17/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Change In Inventory calculated?

Change In Inventory is calculated from a company's financial statements. For ABVC BioPharma (ABVC), the current Change In Inventory is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ABVC BioPharma (ABVC) Overvalued in 2026?

Based on GuruFocus' analysis, ABVC BioPharma stock appears to be overvalued. The current stock price of $1.75 is trading 101.1% above its estimated GF Value™ of $0.87. GuruFocus considers ABVC BioPharma to be Significantly Overvalued.

Key valuation signals for ABVC:

Change In Inventory: $0.00 Mil
GF Value™: $0.87 vs. price of $1.75 (101.1% above fair value)
GF Score™: 17/100 with 1 warning sign

No single metric tells the full story. See the ABVC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ABVC BioPharma Business Description

Industry Healthcare Biotechnology

Comparable Companies GRCE ELOX INMB ESLA NTRB RNXT ACTU ALGS SNTI APLM VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address 44370 Old Warm Springs Boulevard, Fremont, CA, USA, 94538

Website https://www.abvcpharma.com

ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.

17GF Score

Get the complete analysis for ABVC

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.75

Price

$0.87

GF Value

View ABVC Analysis

See Change In Inventory data for all stocks →